Trials / Completed
CompletedNCT00652912
Bioavailability Study of Clonazepam ODT Under Fasting Conditions
Comparative, Randomized, Single-Dose, Bioavailability Study of Kali's Clonazepam ODT 1 mg With That of Klonopin Wafers 1 mg ODT in Healthy Adult Subjects Under Fasting Conditions.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Par Pharmaceutical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT
Detailed description
To compare the single -dose bioavailability of kali's Clonazepam ODT 1 mg with that of Klonopin Wafers 1 mg ODT by Roche pharmaceuticals following a single oral dose under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clonazepam | ODT, 1 mg |
| DRUG | Klonopin Wafers | ODT, 1 mg |
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2004-04-01
- Completion
- 2004-05-01
- First posted
- 2008-04-04
- Last updated
- 2008-04-04
Source: ClinicalTrials.gov record NCT00652912. Inclusion in this directory is not an endorsement.